• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例COVID-19患者罕见的脑血管意外表现:病例报告

A Rare Presentation of Cerebrovascular Accident in a COVID-19 Patient: A Case Report.

作者信息

Sattler Ross, Ekanayake Lakmal S, Richardson Amber

机构信息

Medicine, Ohio University Heritage College of Osteopathic Medicine, Athens, USA.

Internal Medicine, Springfield Regional Medical Center, Springfield, USA.

出版信息

Cureus. 2020 Dec 25;12(12):e12287. doi: 10.7759/cureus.12287.

DOI:10.7759/cureus.12287
PMID:33520495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834551/
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded, positive-sense, enveloped ribonucleic acid (RNA) virus. SARS-CoV-2 and its associated disease coronavirus disease 2019 (COVID-19) has caused a global pandemic in the year 2019-2020. COVID-19 has caused widespread death, economic burden, and overcrowding of hospitals. As of September 2020, there is no reliable pharmacological treatment for patients affected by COVID-19. Herein we present a case of a 41-year-old Caucasian female who presented to the emergency department with flu-like symptoms for the past five days. The patient was admitted for COVID-19 symptoms and subsequently developed COVID-19 associated thrombotic syndrome and ischemic stroke. Below, we discuss risk factors, pathology, and rare manifestations resulting from COVID-19 infection. COVID-19 primarily affects the lungs, but a review of the current literature shows limited cases of ischemic stroke and diffuse thrombosis induced by infection of the novel COVID-19 in relatively healthy individuals with minimal risk factors.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是一种单链、正链、包膜核糖核酸(RNA)病毒。SARS-CoV-2及其相关疾病冠状病毒病2019(COVID-19)在2019年至2020年期间引发了全球大流行。COVID-19导致了广泛的死亡、经济负担以及医院人满为患。截至2020年9月,对于感染COVID-19的患者尚无可靠的药物治疗方法。在此,我们报告一例41岁的白种女性病例,该患者在过去五天出现类似流感的症状后前往急诊科就诊。该患者因COVID-19症状入院,随后发展为COVID-19相关血栓形成综合征和缺血性中风。以下,我们将讨论COVID-19感染导致的危险因素、病理以及罕见表现。COVID-19主要影响肺部,但对当前文献的综述显示,在具有最小风险因素的相对健康个体中,由新型COVID-19感染引起的缺血性中风和弥漫性血栓形成的病例有限。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/7834551/98fcdaf2b4d0/cureus-0012-00000012287-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/7834551/4cf870079f37/cureus-0012-00000012287-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/7834551/a73f6792de87/cureus-0012-00000012287-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/7834551/98fcdaf2b4d0/cureus-0012-00000012287-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/7834551/4cf870079f37/cureus-0012-00000012287-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/7834551/a73f6792de87/cureus-0012-00000012287-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f794/7834551/98fcdaf2b4d0/cureus-0012-00000012287-i03.jpg

相似文献

1
A Rare Presentation of Cerebrovascular Accident in a COVID-19 Patient: A Case Report.1例COVID-19患者罕见的脑血管意外表现:病例报告
Cureus. 2020 Dec 25;12(12):e12287. doi: 10.7759/cureus.12287.
2
Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.COVID-19 感染患者的恶性大脑缺血:病例回顾与组织病理学发现。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105231. doi: 10.1016/j.jstrokecerebrovasdis.2020.105231. Epub 2020 Aug 5.
3
Ischemic Stroke among the Symptoms Caused by the COVID-19 Infection.新型冠状病毒肺炎感染所致症状中的缺血性中风。
J Clin Med. 2020 Aug 19;9(9):2688. doi: 10.3390/jcm9092688.
4
[Acute cerebrovascular accidents associated with SARS-CoV-2 coronavirus infection (COVID-19)].[与严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)感染(2019冠状病毒病)相关的急性脑血管意外]
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(12):109-117. doi: 10.17116/jnevro2020120121109.
5
The impact of COVID-19 on ischemic stroke.新冠疫情对缺血性脑卒中的影响。
Diagn Pathol. 2020 Jun 29;15(1):78. doi: 10.1186/s13000-020-00994-0.
6
Coronaviruses - a new old menace.冠状病毒——新的旧威胁。
Postepy Biochem. 2021 Jan 5;66(4):303-308. doi: 10.18388/pb.2020_357. Print 2020 Dec 31.
7
Unprotected stroke management in an undiagnosed case of Severe Acute Respiratory Syndrome Coronavirus 2 infection.未确诊的严重急性呼吸综合征冠状病毒2感染病例中的无保护卒中管理
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):104981. doi: 10.1016/j.jstrokecerebrovasdis.2020.104981. Epub 2020 May 23.
8
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
9
Multiple Thrombotic Events in a 67-Year-Old Man 2 Weeks After Testing Positive for SARS-CoV-2: A Case Report.一名67岁男性在SARS-CoV-2检测呈阳性两周后发生多次血栓形成事件:病例报告
Am J Case Rep. 2020 Jul 22;21:e925786. doi: 10.12659/AJCR.925786.
10
COVID-19: a conundrum to decipher.COVID-19:一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.

引用本文的文献

1
Moderate procedural confidence improvement following hands-on practice using the hemispherectomy simulator.使用半球切除术模拟器进行实践后,手术信心得到适度提升。
Childs Nerv Syst. 2022 Sep;38(9):1777-1782. doi: 10.1007/s00381-022-05628-y. Epub 2022 Jul 29.

本文引用的文献

1
Intravenous tPA for Acute Ischemic Stroke in Patients with COVID-19.静脉注射 tPA 治疗 COVID-19 患者的急性缺血性脑卒中。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105201. doi: 10.1016/j.jstrokecerebrovasdis.2020.105201. Epub 2020 Jul 27.
2
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2.美国风湿病学会在 COVID-19 大流行期间成人风湿性疾病管理指南:第 2 版。
Arthritis Rheumatol. 2020 Sep;72(9):e1-e12. doi: 10.1002/art.41437. Epub 2020 Jul 30.
3
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.
越来越多的证据表明 COVID-19 存在血栓综合征,这对治疗有影响。
Nat Rev Rheumatol. 2020 Oct;16(10):581-589. doi: 10.1038/s41584-020-0474-5. Epub 2020 Jul 30.
4
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature.COVID-19 与缺血性脑卒中:文献的系统评价和汇总分析。
J Thromb Thrombolysis. 2020 Oct;50(3):587-595. doi: 10.1007/s11239-020-02228-y.
5
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
6
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素:前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
7
Association of inflammatory markers with the severity of COVID-19: A meta-analysis.炎症标志物与 COVID-19 严重程度的相关性:一项荟萃分析。
Int J Infect Dis. 2020 Jul;96:467-474. doi: 10.1016/j.ijid.2020.05.055. Epub 2020 May 18.
8
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
9
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.新冠病毒肺炎患者的狼疮抗凝物与异常凝血检测
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
10
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高:一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.